![overlay-bottom[1]](https://ambrygen.com/wp-content/uploads/2026/02/overlay-bottom1.svg)
Articles Tagged: BRCA1 & 2
March 25, 2026
The CARE Difference: A Smarter Workflow for High‑Risk Screening
Danielle Rogers, oncology and genetics nurse practitioner, recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry…
BRCA1 & 2
Breast Cancer
August 7, 2025
Scaling Early Detection and Prevention: 5 Lessons from HCA Healthcare
Recap of a recent Becker’s Healthcare podcast with Dr. Dax Kurbegov, who shared how his team is building a scalable model for risk assessment and…
BRCA1 & 2
Cancer Risk
Genetic Testing
Hereditary Cancer
June 4, 2025
Personalized Care in Action: The Unexpected Discovery That Validated Our High-Risk Program
Lisa McGuire shares how a combination of innovative technology and dedicated healthcare teams can transform patient outcomes.
BRCA1 & 2
Breast Cancer
Breast Cancer Awareness
Cancer Risk
Hereditary Cancer
Reduce Risks
October 31, 2024
Early Detection in Action: Angie’s CARE Story
One CARE patient’s story demonstrates the power of proactive care and comprehensive high-risk screening.
BRCA1 & 2
Breast Cancer
October 17, 2024
The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment
Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.
BRCA1 & 2
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Ovarian Cancer
Variant of Unknown Significance
VUS
July 17, 2024
Expanding Your High-Risk Breast Program: Best Practices for Growth and Impact
Nurse Adrianne Alexander shares practical, engaging, and impactful best practices to expand a high-risk breast program.
BRCA1 & 2
Breast Cancer
Breast Cancer Awareness
Cancer Risk
Genetic Testing
OBGYN
Risk Factors
